Glioma has been regarded as the most common, highly proliferative and invasive brain tumour. Advances in research of miRNAs in glioma are toward further under-
| INTRODUCTION
MicroRNAs, a class of endogenous non-coding RNA with [18] [19] [20] [21] [22] [23] [24] [25] nucleotides, repress the expression of corresponding genes by binding to the 3′-UTR region of target genes at post-transcriptional level. 1, 2 MiRNAs have been identified to participate in a variety of cell biological processes such as proliferation, apoptosis, migration and invasion. 3, 4 During the development of cancer, miRNAs are dysregulated and play oncogenic or tumour suppressive role by enhancing or suppressing proliferation, invasion of tumour cells. 5, 6 Thus, miRNA deregulation is one of the key mechanisms in glioma pathogenesis. The relevant miRs can be used as new targets of glioma therapy and provide clues for diagnosis.
This review will discuss the role of miR-19 in glioma cell proliferation, apoptosis and migration and its effect on chemotherapy and radiotherapy of glioma.
MiR-19 is a member of miR-17-92 cluster, this cluster participates not only in the development of heart and lung, 7, 8 but also in ageing and cancer. 9 The target genes of miR-17-92 cluster have been experimentally identified so far including: STAT3, Mapk14 10 and Rb2/p130. 11 MiR-17-92 cluster plays an important role in tumourigenesis of thyroid cancer, leukaemia and lymphoma. [12] [13] [14] The expression of miR-17-92 cluster is up-regulated in glioma tissues. MiR-17-92 cluster inhibition decreases cell proliferation and induces apoptosis in glioblastoma spheroids culture by upregulating the expression of CDKN1A (cyclin-dependent kinase inhibitor 1A), E2F1 and PTEN. 15 MiR-17-92 cluster is regarded as the first miRNA cluster with oncogenic potential, 15 Figure 1 ). 24 which play a significant role in glioma pathogenesis and progression. The effect of miR-19 on glioma cell proliferation, apoptosis and migration and the impact of miR-19 on chemotherapy and radiation therapy of glioma will be discussed separately as follows.
| MIR-19 IN GLIOMA

| MiR-19 and apoptosis
Studies demonstrate that miR-19 inhibits apoptosis of glioma cells.
Anti-miR-19 (antisense oligonucleotide of miR-19) is introduced to knock down miR-19 expression, apoptosis is induced in glioma cells. 28 We have confirmed PTEN as the target gene of miR-19
experimentally. 24 PTEN plays a significant role as a tumour suppressor gene that induces glioma cell apoptosis and as a negative regulator of PI3K/AKT pathway, whereas PI3K/AKT inhibits apoptosis through repressing JNK and p38, or promoting FoxM1 expression in glioma. 29 , 30 Wang also reported that miR-19 was suppressed by resveratrol in glioma and induced apoptosis, PTEN up-regulation and 
| MiR-19 and cell migration
It has been demonstrated that knocking down miR-19 suppresses migration of glioma cell, 28 whereas overexpression of miR-19 promotes glioma cell migration and invasion. Long nocoding RNA:
MEG3 suppresses glioma cell migration by playing a role as competing endogenous RNA (ceRNA) of miR-19. 46 As to the target genes of miR-19 relevant to glioma cell invasion, it has been reported that RUNX3 suppresses glioma cell invasion by depressing the transcrip- 53 and promotes cell metastasis in hepatocellular carcinoma. 54 However, miR-19 exerts inhibitory effect on the ability of breast cancer cell migration and invasion, 55 and it also inhibits migration and invasion of colon cancer cell by suppressing MMP9 and tissue factor (TF). inhibitor, the expression of its target genes will be regulated accordingly, so it is predictable that multiple genes therapeutic effect can be achieved if novel anti-oncomiR-19 measures are adopted.
| MiR-19 and radiotherapy and chemotherapy sensitivity of glioma
In order to improve the prognosis of patients, malignant glioma patients are given radiotherapy and chemotherapy simultaneously after surgical resection. However, resistance to radiotherapy and chemotherapy turn out to be the important source of glioma recurrence.
MiR-19 has been reported to exert effects on drug resistance by suppressing EGFR/AKT pathway. 64 However, RhoB induces
The role of miR-19 in proliferation, migration, apoptosis and treatment of glioma radioresistance in glioma cells. 65 It has been identified that CtIP is the target gene of miR-19 and CtIP plays a role in the DNA end resection and homologous recombination in response to DNA damage. 66 Then we can infer that miR-19 aberrant expression down-regulating CtIP suppresses the repair of the most hazardous type of lesion, DNA double-strand breaks induced by ionizing radiation, and may be helpful to enhance the effect of radiotherapy. Certainly, this assumption will be contradictory to the anti-miR-19 therapy for its oncogenic potential in glioma and the relationship between miR-19 and radiation response of glioma needs to be investigated further.
| CON CLUSION AND PERSPECTIVE
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